In this twenty-first episode, Nichola Conlon provides a scientific background, introducing sirtuins and NAD. She then explains why popular NAD+ boosters, NR and NMN, are first-gen products. She details how Nuchido formulated the first second-gen product by taking a novel whole systems approach. Lots of NAD, anti-aging, and nutraceutical discussion along the way.
Welcome Lee: Hello, and welcome Nichola Conlon as guest number 21 in the Quantified Health, Wellness, and Aging podcast. Nichola: Hi, Lee. Thanks for having me. Lee: “Why aye, man!” Nichola: Do you recognize my accent? Lee: I do. Nichola: People that haven’t got any experience of the UK often think I’m Scottish, but I live quite close, but not... Read MoreNR vs NMN is Dated, Boosting NAD+ to New Levels – EP21: Nichola Conlon (Nuchido)
I’ve heard (and watched) several interviews with the vivacious Elizabeth (Liz) Parrish. Recently I heard her twice on The Future Tech Podcast. I found the first interview to be very concise and therefore introductory for people not yet familiar with gene therapy as an emergent tool to treat biological aging (regenerative medicine). In 2015, Liz flew to Bogotá (Columbia) and... Read MoreAnti-Aging Gene Therapies—Elizabeth Parrish (CEO, BioViva)